Linking HTA and Procurement: Forum Discussion on Assessing the Value of Medical Device - ISPOR SIG MD&D Key Project Presentation


Moderator: Arthi Chandran, MS, MPH, DPH, Abbott, Santa Clara, CA, USA
Speakers: Michael Joseph Cangelosi, MA, MPH, Boston Scientific Corporation, Natick, MA, USA; Simon Eggington, MSc, Medtronic International Trading Sarl, Tolochenaz, VD, Switzerland; Akriti Chahar, MA, PhD Scholar, IQVIA, Gurgaon, India

Presentation Documents

The ISPOR Medical Device and Diagnostics Special Interest Group (MDD-SIG) is conducting a key project to characterize the usage of Health Technology Assessment (HTA) in procurement decisions. The goal of this forum is to discuss methods and initial results, and to engage the ISPOR community to inform and prioritize next steps. HTA is used to inform decision-making on the coverage and use of medical device and diagnostic technologies at the centralized, macroeconomic level and offers the potential of robust methods to help inform micro-level procurement decisions. Such use could reduce variation in access to these technologies; however, the nature of this use is not well characterized. Initial findings (predominantly from high-income countries) show that decision makers made their recommendations parallel to HTA by considering clinical data, cost-effectiveness, and safety; only a minority are based on HTA summaries and conclusions. There is little publication evidence of the generalizable link between HTA and procurement. Planned next steps involve a survey of relevant HTA and procurement stakeholders. This forum will elicit feedback on the most up-to-date version of that survey; attendees will have the opportunity to provide feedback and suggest prioritized next steps via ranking, polls, and open discussion. Discussion in this forum will include: mechanisms to increase the participation of the survey and finalize pertinent survey questions, the relative importance of different aspects of HTA in procurement decision-making, the costs and benefits of potentially duplicative assessments at the macro and micro levels, the role of the grey literature, and the role of ISPOR and its SIGs to better connect the HTA and procurement communities. The concluding period will allow for wrap up, questions, and review next steps. We welcome forum participation from MDD-SIG members, HTA professionals, payers, and anyone playing a role within or interested in medical technology procurement.

Conference/Value in Health Info

2021-11, ISPOR Europe 2021, Copenhagen, Denmark



Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now